T1	Participants 13 46	advanced hepatocellular carcinoma
T2	Participants 87 113	two French clinical trials
T3	Participants 217 259	Cancer of the Liver Italian Program (CLIP)
T4	Participants 264 305	Barcelona Clinic Liver Cancer group (BCLC
T5	Participants 350 379	hepatocellular carcinoma (HCC
T6	Participants 443 510	French patients with HCC whose main etiology is alcoholic cirrhosis
T7	Participants 658 687	included 416 and 122 patients
